A new “MIGS” or microimplant for Glaucoma surgery called I-stent has appeared as a novelty.
It is indicated to reduce intraocular pressure in patients with mild or moderate open-angle glaucoma, that is, for patients who are usually treated with two glaucoma drugs and who are supervised under this treatment.
The objective is to perform a first step in the treatment of this disease, with a minimally invasive technique and practically without side effects. This is achieved by improving a step in the evolution of this pathology and reducing or eliminating the use of eye drops for a while. It has appeared to be performed individually or in association with cataract surgery, taking advantage of the same incision through which we enter the eye.
The complications in its implementation are minimal because it is the smallest device on the market with this purpose. It is dispensed through a micro-injector where there are two pre-loaded devices, and with the help of a special lens they are implanted in the trabecular meshwork. This is the place where the collecting channels for the expulsion of the aqueous humor of the eye, which favors the elimination of aqueous humor through its physiological way. When an increase in eye pressure is detected, the liquid is filtered through these microtubes with holes
At the same time, the risk of ocular tension reduction decreases respect to other similar procedures, and this preserves the episcleral circulation of the trabecular meshwork, not allowing the exit of aqueous humor from the eye when it is not necessary.
Actually, and if all goes well, it is that for a while it may not need more treatment with drops, the toxicity that they produce in the ocular surface all ocular topical treatments used chronically cancel out, and of those that are dependent glaucoma patients Life Habits and Glaucoma l.
Recent Comments